4.7 C
Saturday, April 20, 2024
HomeScience"Synthetic" mouse embryos grow a brain, nerve cord, and beating heart.

“Synthetic” mouse embryos grow a brain, nerve cord, and beating heart.

If applied to human embryos, the discovery could aid in the understanding of human fertility, and developmental abnormalities, and provide a new path for developing lab-grown tissues or organs for transplantation.

A team of scientists from the United Kingdom and the United States has generated “synthetic” mouse embryos that developed a brain, a spinal cord, and beating heart tissue in the laboratory without the requirement for a fertilized egg or uterus.

It is comparable to a breakthrough revealed earlier this month by an Israeli team. Together, the achievements have the potential to revolutionize our knowledge of one of the greatest challenges in biology: how a few cells organize into life.

"synthetic" mouse embryos grow a brain, nerve cord, and beating heart.

If applied to human embryos, the discovery could contribute to a greater understanding of human fertility, and developmental abnormalities, and offer a novel way to generate lab-grown tissues or organs for donation.

However, the application of this technology to human embryos would create significant ethical and legal concerns.

How we begin our lives is the central subject being addressed in the lab. Professor Magdalena Zernicka-Goetz of Caltech in Pasadena, California, and Cambridge University in the United Kingdom explains.

"synthetic" mouse embryos grow a brain, nerve cord, and beating heart.
"synthetic" mouse embryos grow a brain, nerve cord, and beating heart.

To build synthetic embryos, or “embryoids,” scientists extracted three types of stem cells from a mouse embryo that would usually form all the necessary tissues for a developing fetus.

They next put the cells into an artificial growth media, which consisted of nutrients in a flask that rotated.

The stem cells spontaneously developed into embryos.

Prof. Zernicka-Goetz asserts that the few successful embryos “are essentially indistinguishable from natural embryos in many instances.”

The embryos only matured for eight and a half days, which is roughly half of a mouse’s normal gestation length.

However, the technology should remain incredibly significant as a means of creating early embryos for studying early development without using animals.

The team is currently hard at work on a human embryo model, but they emphasize that it is still a ways off. Significant distinctions exist between early mouse development and early human development.

Having a synthetic human embryo, however, could be a significant step forward for the research of fertility and common developmental diseases.

According to Prof. Zernicka-Goetz, the majority of human babies are lost in the very early stages of life, and 20 to 70 percent of IVF attempts fail.

Donated human embryos are scarce and frequently of low quality, therefore a “model” embryo generated in a laboratory could assist address numerous problems.

The team proposes synthetic embryoids that reproduce only a single component of an early human embryo, such as the heart or the tissue that develops the placenta. Failure at implantation is a leading cause of IVF pregnancy failure.

In “regenerative” medicine, synthetic human embryos could also be used to generate new tissues or organs. Such tissues could be a perfect match for the recipient if produced from the patient’s stem cells.

However, generating synthetic human embryos would necessitate a change in the current law in the United Kingdom, which does not permit the growth of embryos from stem cells.

The law of the United Kingdom prohibits the cultivation of human embryos in the laboratory beyond 14 days. This occurs before the majority of the significant developmental processes are observed in these mouse embryos.

According to experts, the discussion of these legal and ethical problems should commence sooner rather than later in light of this most recent demonstration.

Prof. Alfonso Martinez Arias of the Universitat Pompeu Fabra in Barcelona, who was not involved in the study, thinks that the findings indicate that similar experiments with human cells will be conducted in the future and will eventually produce similar outcomes.

“This should prompt questions of the ethics and societal effect of these studies before they are conducted,” he added.


This site uses Akismet to reduce spam. Learn how your comment data is processed.

Most Popular

Police threaten arrest of ‘openly Jewish’ man near pro-Palestine march

Last Saturday in London, the leader of the Campaign Against Antisemitism was prevented from crossing a road near a pro-Palestine demonstration. A supporter of antisemitism was threatened with arrest mere yards from a pro-Palestine march, with one Metropolitan Police officer characterising his presence as "antagonising."

G7 nations criticise Chinese funding for Russia’s weapons industry

The "strong concern" expressed by foreign ministers of the Group of Seven (G7) nations regarding transferring weapon components and materials from Chinese enterprises to Russia in preparation for its military offensive in Ukraine has been documented. US Secretary of State Antony Blinken exhorted his counterparts on Friday at a meeting on the Italian island of Capri to increase pressure on China, which the United States accuses of assisting Russia's war effort by supplying critical components for weaponry.

Israel’s attack on Iran: Crisis demonstrates Iran-Israel miscommunication

The Israeli assault on Iran did not elicit the severe reaction that Western leaders, including US President Joe Biden, had anticipated. They have been advocating for Israel to establish a clear boundary in the perilous sequence of occurrences that commenced on April 1 with the assassination of a senior Iranian general in Damascus by Israel. The conflict in Gaza has persisted for over six months after the Hamas assaults on Israel, and it has extended to the vicinity encompassing the Lebanon-Israel border and the Gulf.

Saga boosted by ocean and river cruise demand

New results indicate that Saga's cruise and travel divisions returned to profitability in 2018 due to a significant increase in demand. According to preliminary annual results, the group's ocean cruise division generated an underlying pre-tax profit of £35.5 million in the year ending in January, compared to a loss of £700,000 in the prior year. The organisation stated, "Bookings for ocean cruises continue to be exceptionally robust, and we have already secured a 78% load factor and £3,679 per diem for 2024/25."

Recent Comments